The recent Antimicrobial Resistance (AMR) conference brought together healthcare professionals, researchers, and policymakers to discuss the urgent need to address this growing global health crisis. The event featured a diverse range of presentations, panel discussions, and interactive sessions, all aimed at raising awareness, sharing knowledge, and fostering collaboration.
Key Presenters and Their Insights:
• Mr. Robert Wagubi, Lab Manager at MRRH, presented on the evolution, structure, objectives, and impact of the Antimicrobial Stewardship Committee at MRRH. He highlighted the critical role of antibiograms in guiding effective treatment decisions.
• Associate Professor Joel Bazira addressed AMR as a pressing global health challenge, covering key concepts, impacts, and strategies at both global and national levels, as well as notable achievements and ongoing challenges. He emphasized the role of genetics in AMR mechanisms and implications, highlighting human activity as a critical factor in AMR development.
Associate Professor Joel Bazira challenged Angella Nakato Muyingo,MUST’s PRO to explain AMR in layman’s terms and then translate it into Luganda. He also challenged Dr. Emmanuel Munyarugyero to translate it into Kifumbira.
Bazira questioned whether the community truly understood the term AMR, given the complexity of its explanation. He urged the organizers to invite community members, especially leaders, to future events. He emphasized that the knowledge about AMR shouldn’t be confined to healthcare professionals but should be disseminated widely to the community.
• Dr. Joseph Oloro emphasized the importance of handwashing, regular use of hand sanitizers, and being vigilant for each other’s health. He advocated for evidence-based medicine and treatment practices as key steps in combating AMR.
• Sr. Dorothy Ajambo, representing the IPC Team from MRRH, discussed the critical role of antimicrobial stewardship and shared the core goals of Infection Prevention and Control (IPC) at the AMR conference.
• Dr. Miriam Nakiwula Josephine presented findings from a baseline assessment on the current state of AMR in the ICU, shedding light on critical challenges and opportunities for improvement in patient care.
• Dr. Daniel Chans Mwandah, the PI of the project, delivered a compelling presentation on baseline assessment findings and the use of biomarkers for rapid infection identification in ICUs, providing valuable insights at the AMR conference.
Key Highlights from the Conference:
• Understanding AMR: Experts explained the complex mechanisms of AMR, highlighting the role of genetics and human activities in its development. The importance of antibiograms in guiding effective treatment decisions was emphasized.
• Global and National Strategies: Participants discussed global and national strategies to combat AMR, including surveillance, infection prevention and control, and responsible antibiotic use. The challenges and successes in implementing these strategies were shared.
• The Role of Healthcare Professionals: Healthcare professionals were encouraged to play a crucial role in the fight against AMR by adhering to evidence-based practices, promoting hand hygiene, and advocating for appropriate antibiotic use.
• Community Engagement: The importance of public awareness and community engagement was highlighted. Engaging and informative presentations were delivered to the public in accessible language to promote understanding and behavior change.
• Research and Innovation: Researchers presented findings on baseline assessments, biomarker identification, and other innovative approaches to combat AMR. The need for continued research and investment in this area was emphasized.
By fostering dialogue and sharing knowledge, the AMR conference provided a platform to inspire action and drive meaningful change. Together, we can confront the silent threat of antimicrobial resistance and protect future generations.
Dr. Jonans Tusiimire, Deputy Dean of the Faculty of Medicine, conveyed a message of appreciation from the Dean, encouraging the team to pursue research that addresses key questions and supports the National Drug Authority (NDA) and policymakers in drug regulation and brand control. He thanked all participants, particularly the ICU team, for taking time out of their busy schedules to attend. He extended special recognition and thanks to Dr. Tendo Stephen, Dr. Emmanuel Muyarugyero, and Sr. Dorothy Ajambo.
In line with the University’s mission to provide equitable quality and relevant education and research with a particular emphasis on Science and Technology and its application to community development, Dr. Chans has exemplified this commitment through his work on AMR. The University acknowledges the importance of addressing AMR and supports initiatives to combat this pressing global health challenge. MUST is committed to informing and empowering our audience. Stay tuned for more updates on the latest advancements in healthcare and public health.
